Zkusit zdarma
Kymera Therapeutics, Inc.

Kymera Therapeutics, Inc.

KYMR
Cena:
$ 78.89
-1.72 (-2.13%)
Valuace
70
Růst
0
Zdraví
75
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
Kymera Therapeutics Announces Presentations on KT-621, a First-In-Class, Oral STAT6 Degrader, at the Society for Investigative Dermatology and American Thoracic Society Congresses

Kymera Therapeutics Announces Presentations on KT-621, a First-In-Class, Oral STAT6 Degrader, at the Society for Investigative Dermatology and American Thoracic Society Congresses

7:00 15-05-2026

Late-breaking presentation at SID and featured presentation at the ATS Respiratory Innovation Summit...

Kymera Therapeutics, Inc. (KYMR) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Kymera Therapeutics, Inc. (KYMR) Presents at Bank of America Global Healthcare Conference 2026 Transcript

14:50 12-05-2026

Kymera Therapeutics, Inc. (KYMR) Presents at Bank of America Global Healthcare Conference 2026 Trans...

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Kymera Therapeutics, Inc. (NASDAQ: KYMR)

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Kymera Therapeutics, Inc. (NASDAQ: KYMR)

11:00 12-05-2026

SHAREHOLDER ALERT: Purcell and Lefkowitz LLP Announces Shareholder Investigation of Kymera Therapeut...

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Kymera Therapeutics, Inc. (NASDAQ: KYMR)

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Kymera Therapeutics, Inc. (NASDAQ: KYMR)

10:00 12-05-2026

NEW YORK, May 12, 2026 /PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating Ky...

Kymera Therapeutics to Participate in Upcoming May Investor Conferences

Kymera Therapeutics to Participate in Upcoming May Investor Conferences

7:00 06-05-2026

WATERTOWN, Mass., May 06, 2026 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clini...

KYMR Q1 Earnings Top Estimates, Revenues Gain on GILD Collaboration

KYMR Q1 Earnings Top Estimates, Revenues Gain on GILD Collaboration

15:10 01-05-2026

Kymera Therapeutics tops Q1 revenue estimates on strong Gilead collaboration, as pipeline advances a...

Kymera Therapeutics, Inc. (KYMR) Q1 2026 Earnings Call Transcript

Kymera Therapeutics, Inc. (KYMR) Q1 2026 Earnings Call Transcript

13:51 30-04-2026

Kymera Therapeutics, Inc. (KYMR) Q1 2026 Earnings Call Transcript...

Kymera Therapeutics, Inc. (KYMR) Reports Q1 Loss, Tops Revenue Estimates

Kymera Therapeutics, Inc. (KYMR) Reports Q1 Loss, Tops Revenue Estimates

9:35 30-04-2026

Kymera Therapeutics, Inc. (KYMR) came out with a quarterly loss of $0.71 per share versus the Zacks ...

B. Metzler seel. Sohn & Co. AG Purchases New Holdings in Kymera Therapeutics, Inc. $KYMR

B. Metzler seel. Sohn & Co. AG Purchases New Holdings in Kymera Therapeutics, Inc. $KYMR

3:48 27-04-2026

B. Metzler seel. Sohn and Co. AG purchased a new stake in shares of Kymera Therapeutics, Inc. (NASDA...

Kymera Therapeutics to Report First Quarter 2026 Financial Results on April 30, 2026

Kymera Therapeutics to Report First Quarter 2026 Financial Results on April 30, 2026

7:00 23-04-2026

WATERTOWN, Mass., April 23, 2026 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a cli...

Insider Selling: Kymera Therapeutics (NASDAQ:KYMR) Director Sells $374,185.23 in Stock

Insider Selling: Kymera Therapeutics (NASDAQ:KYMR) Director Sells $374,185.23 in Stock

4:36 19-04-2026

Kymera Therapeutics, Inc. (NASDAQ: KYMR - Get Free Report) Director Bruce Booth sold 4,159 shares of...

Insider Selling: Kymera Therapeutics (NASDAQ:KYMR) COO Sells $472,590.00 in Stock

Insider Selling: Kymera Therapeutics (NASDAQ:KYMR) COO Sells $472,590.00 in Stock

4:36 19-04-2026

Kymera Therapeutics, Inc. (NASDAQ: KYMR - Get Free Report) COO Jeremy Chadwick sold 5,251 shares of ...

KYMR Stock Up as FDA Grants Fast Track Designation to Asthma Drug

KYMR Stock Up as FDA Grants Fast Track Designation to Asthma Drug

13:41 14-04-2026

Kymera Therapeutics shares jump after FDA grants Fast Track to KT-621 for eosinophilic asthma, spotl...

Kymera: 'Strong Buy' On Continued Success With KT-621 In Th2-Driven Disorders

Kymera: 'Strong Buy' On Continued Success With KT-621 In Th2-Driven Disorders

15:12 13-04-2026

Kymera Therapeutics remains a "Strong Buy", driven by positive phase 1b data for KT-621 in atopic de...

KYMR Set to Earn Milestone Payment as GILD Secures License for KT-200

KYMR Set to Earn Milestone Payment as GILD Secures License for KT-200

13:06 10-04-2026

Kymera Therapeutics secures $45M as Gilead licenses KT-200, advancing a novel CDK2 degrader with pot...

SG Americas Securities LLC Grows Position in Kymera Therapeutics, Inc. $KYMR

SG Americas Securities LLC Grows Position in Kymera Therapeutics, Inc. $KYMR

5:03 06-04-2026

SG Americas Securities LLC boosted its position in shares of Kymera Therapeutics, Inc. (NASDAQ: KYMR...

Kymera Therapeutics (NASDAQ:KYMR) COO Jeremy Chadwick Sells 14,640 Shares

Kymera Therapeutics (NASDAQ:KYMR) COO Jeremy Chadwick Sells 14,640 Shares

4:48 03-04-2026

Kymera Therapeutics, Inc. (NASDAQ: KYMR - Get Free Report) COO Jeremy Chadwick sold 14,640 shares of...

Kymera Therapeutics (NASDAQ:KYMR) Director Elena Ridloff Sells 7,400 Shares of Stock

Kymera Therapeutics (NASDAQ:KYMR) Director Elena Ridloff Sells 7,400 Shares of Stock

4:48 03-04-2026

Kymera Therapeutics, Inc. (NASDAQ: KYMR - Get Free Report) Director Elena Ridloff sold 7,400 shares ...

Kymera Therapeutics (NASDAQ:KYMR) COO Jeremy Chadwick Sells 7,600 Shares of Stock

Kymera Therapeutics (NASDAQ:KYMR) COO Jeremy Chadwick Sells 7,600 Shares of Stock

4:47 03-04-2026

Kymera Therapeutics, Inc. (NASDAQ: KYMR - Get Free Report) COO Jeremy Chadwick sold 7,600 shares of ...

Kymera Therapeutics Presents KT-621 BroADen Data in Late-Breaking Research Session at the American Academy of Dermatology (AAD) Annual Meeting

Kymera Therapeutics Presents KT-621 BroADen Data in Late-Breaking Research Session at the American Academy of Dermatology (AAD) Annual Meeting

11:00 28-03-2026

Featured presentation highlights positive BroADen Phase 1b atopic dermatitis trial results supportin...

close

KYMERA THERAPEUTICS OUTLINES KEY 2026 OBJECTIVES AND STRATEGY TO ADVANCE INDUSTRY LEADING PORTFOLIO OF ORAL IMMUNOLOGY PROGRAMS

13-01-2026
KT-621 BROADEN2 PHASE 2B TRIAL IN AD ONGOING, WITH DATA EXPECTED BY MID-2027 KT-621 BREADTH PHASE 2B...
Více zde

KYMERA THERAPEUTICS ANNOUNCES CLOSING OF UPSIZED $602 MILLION PUBLIC OFFERING AND FULL EXERCISE OF UNDERWRITERS' OPTION TO PURCHASE ADDITIONAL SHARES

11-12-2025
WATERTOWN, MASS., DEC. 11, 2025 (GLOBE NEWSWIRE) -- KYMERA THERAPEUTICS, INC. (NASDAQ: KYMR), A CLIN...
Více zde

KYMERA THERAPEUTICS ANNOUNCES PROPOSED PUBLIC OFFERING

08-12-2025
WATERTOWN, MASS., DEC. 08, 2025 (GLOBE NEWSWIRE) -- KYMERA THERAPEUTICS, INC. (NASDAQ: KYMR), A CLIN...
Více zde

KYMERA THERAPEUTICS ANNOUNCES POSITIVE RESULTS FROM BROADEN PHASE 1B CLINICAL TRIAL OF KT-621, A FIRST-IN-CLASS, ORAL STAT6 DEGRADER, IN PATIENTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS

08-12-2025
KT-621 ACHIEVED DEEP STAT6 DEGRADATION ACROSS BOTH THE 100 MG AND 200 MG DOSE GROUPS TESTED, WITH ME...
Více zde

KYMERA THERAPEUTICS TO ANNOUNCE KT-621 BROADEN PHASE 1B ATOPIC DERMATITIS TRIAL RESULTS ON DECEMBER 8, 2025

05-12-2025
COMPANY TO HOST VIDEO CONFERENCE CALL AND WEBCAST AT 8:00 A.M. ET ON MONDAY, DECEMBER 8, 2025 WATERT...
Více zde

KYMERA THERAPEUTICS ANNOUNCES FIRST PATIENT DOSED IN BROADEN2 PHASE 2B ATOPIC DERMATITIS CLINICAL TRIAL OF KT-621, A FIRST-IN-CLASS, ORAL STAT6 DEGRADER

25-11-2025
DATA FROM THE KT-621 BROADEN2 PHASE 2B AD PATIENT TRIAL EXPECTED TO BE REPORTED BY MID-2027 KT-621 B...
Více zde

KYMERA THERAPEUTICS TO PARTICIPATE IN UPCOMING DECEMBER INVESTOR CONFERENCES

24-11-2025
WATERTOWN, MASS., NOV. 24, 2025 (GLOBE NEWSWIRE) -- KYMERA THERAPEUTICS, INC. (NASDAQ: KYMR), A CLI...
Více zde

KYMERA THERAPEUTICS TO PARTICIPATE IN UPCOMING NOVEMBER INVESTOR CONFERENCES

03-11-2025
WATERTOWN, MASS., NOV. 03, 2025 (GLOBE NEWSWIRE) -- KYMERA THERAPEUTICS, INC. (NASDAQ: KYMR), A CLIN...
Více zde

KYMERA THERAPEUTICS TO REPORT THIRD QUARTER 2025 FINANCIAL RESULTS ON NOVEMBER 4, 2025

28-10-2025
WATERTOWN, MASS., OCT. 28, 2025 (GLOBE NEWSWIRE) -- KYMERA THERAPEUTICS, INC. (NASDAQ: KYMR), A CLIN...
Více zde

KYMERA THERAPEUTICS PRESENTS NEW PRECLINICAL DATA FOR KT-579, A FIRST-IN-CLASS, ORAL IRF5 DEGRADER, AT THE AMERICAN COLLEGE OF RHEUMATOLOGY ANNUAL MEETING

27-10-2025
KT-579, A POTENT, SELECTIVE, ORAL DEGRADER OF IRF5, DEMONSTRATED BROAD ACTIVITY ACROSS MULTIPLE PREC...
Více zde

KYMERA THERAPEUTICS APPOINTS BRIAN ADAMS AS CHIEF LEGAL OFFICER AND CORPORATE SECRETARY

03-09-2025
WATERTOWN, MASS., SEPT. 03, 2025 (GLOBE NEWSWIRE) -- KYMERA THERAPEUTICS, INC. (NASDAQ: KYMR), A CLI...
Více zde

KYMERA THERAPEUTICS TO PARTICIPATE IN UPCOMING SEPTEMBER INVESTOR CONFERENCES

27-08-2025
WATERTOWN, MASS., AUG. 27, 2025 (GLOBE NEWSWIRE) -- KYMERA THERAPEUTICS, INC. (NASDAQ: KYMR), A CLIN...
Více zde

KYMERA THERAPEUTICS ANNOUNCES SECOND QUARTER 2025 FINANCIAL RESULTS AND PROVIDES A BUSINESS UPDATE

11-08-2025
REPORTED POSITIVE KT-621 (STAT6) PHASE 1 HEALTHY VOLUNTEER DATA SURPASSING KYMERA'S TARGET PRODUCT P...
Více zde

KYMERA THERAPEUTICS ANNOUNCES PRICING OF $250 MILLION PUBLIC OFFERING

26-06-2025
WATERTOWN, MASS., JUNE 26, 2025 (GLOBE NEWSWIRE) -- KYMERA THERAPEUTICS, INC. (NASDAQ: KYMR), A CLIN...
Více zde

KYMERA THERAPEUTICS ANNOUNCES PROPOSED PUBLIC OFFERING

25-06-2025
WATERTOWN, MASS., JUNE 25, 2025 (GLOBE NEWSWIRE) -- KYMERA THERAPEUTICS, INC. (NASDAQ: KYMR), A CLIN...
Více zde

KYMERA THERAPEUTICS ANNOUNCES SANOFI IRAK4 COLLABORATION UPDATE

25-06-2025
SANOFI TO ADVANCE KYMERA'S NEXT-GENERATION ORAL IRAK4 DEGRADER DEVELOPMENT CANDIDATE, KT-485, INTO C...
Více zde

GILEAD SCIENCES AND KYMERA THERAPEUTICS ENTER INTO EXCLUSIVE OPTION AND LICENSE AGREEMENT TO DEVELOP NOVEL ORAL MOLECULAR GLUE CDK2 DEGRADERS

25-06-2025
FOSTER CITY, CALIF. & WATERTOWN, MASS.--(BUSINESS WIRE)--GILEAD SCIENCES, INC. (NASDAQ: GILD) AND KY...
Více zde

KYMERA THERAPEUTICS ANNOUNCES POSITIVE FIRST-IN-HUMAN RESULTS FROM PHASE 1 HEALTHY VOLUNTEER CLINICAL TRIAL OF KT-621, A FIRST-IN-CLASS, ORAL STAT6 DEGRADER

02-06-2025
PHASE 1 HEALTHY VOLUNTEER DATA OF KT-621, A ONCE-A-DAY STAT6 DEGRADER, SURPASS KYMERA'S TARGET PRODU...
Více zde

KYMERA THERAPEUTICS TO ANNOUNCE KT-621 PHASE 1 HEALTHY VOLUNTEER TRIAL RESULTS ON JUNE 2, 2025

30-05-2025
COMPANY TO HOST VIDEO WEBCAST AT 8:00 A.M. ET ON MONDAY, JUNE 2, 2025 COMPANY TO HOST VIDEO WEBCAST ...
Více zde

KYMERA THERAPEUTICS TO PARTICIPATE IN UPCOMING JUNE INVESTOR CONFERENCES

29-05-2025
WATERTOWN, MASS., MAY 29, 2025 (GLOBE NEWSWIRE) -- KYMERA THERAPEUTICS, INC. (NASDAQ: KYMR), A CLINI...
Více zde

KYMERA THERAPEUTICS PRESENTS NEW PRECLINICAL DATA FOR KT-621, A FIRST-IN-CLASS, ORAL STAT6 DEGRADER AT THE AMERICAN THORACIC SOCIETY INTERNATIONAL CONFERENCE

19-05-2025
KT-621, A POTENT, SELECTIVE, ORAL STAT6 DEGRADER, DEMONSTRATED COMPARABLE OR SUPERIOR ACTIVITY TO DU...
Více zde

KYMERA THERAPEUTICS EXPANDS INDUSTRY LEADING IMMUNOLOGY PIPELINE WITH NEW FIRST-IN-CLASS, ORAL IRF5 DEGRADER PROGRAM WITH POTENTIAL TO ADDRESS MULTIPLE IMMUNO-INFLAMMATORY DISEASES

09-05-2025
IRF5 PROGRAM STRENGTHENS KYMERA'S ORAL IMMUNOLOGY PIPELINE WITH A COMPLEMENTARY MECHANISM TO EXPAND ...
Více zde

KYMERA THERAPEUTICS ANNOUNCES FIRST QUARTER 2025 FINANCIAL RESULTS AND PROVIDES A BUSINESS UPDATE

09-05-2025
COMPLETED KT-621 (STAT6) SAD/MAD PHASE 1 HEALTHY VOLUNTEER TRIAL WITH DATA TO BE REPORTED IN JUNE 20...
Více zde

KYMERA THERAPEUTICS TO PARTICIPATE IN FIRESIDE CHAT AT THE BOFA SECURITIES 2025 HEALTH CARE CONFERENCE

07-05-2025
WATERTOWN, MASS., MAY 07, 2025 (GLOBE NEWSWIRE) -- KYMERA THERAPEUTICS, INC. (NASDAQ: KYMR), A CLINI...
Více zde

KYMERA THERAPEUTICS ANNOUNCES FIRST PATIENT DOSED IN BROADEN PHASE 1B ATOPIC DERMATITIS CLINICAL TRIAL OF KT-621, A FIRST-IN-CLASS ORAL STAT6 DEGRADER

22-04-2025
DATA FROM THE BROADEN PHASE 1B ATOPIC DERMATITIS (AD) PATIENT TRIAL EXPECTED TO BE REPORTED IN 4Q25 ...
Více zde

KYMERA THERAPEUTICS APPOINTS NOAH GOODMAN AS CHIEF BUSINESS OFFICER

09-04-2025
WATERTOWN, MASS., APRIL 09, 2025 (GLOBE NEWSWIRE) -- KYMERA THERAPEUTICS, INC. (NASDAQ: KYMR), A CLI...
Více zde

KYMERA THERAPEUTICS TO PARTICIPATE IN UPCOMING MARCH INVESTOR CONFERENCES

26-02-2025
WATERTOWN, MASS., FEB. 26, 2025 (GLOBE NEWSWIRE) -- KYMERA THERAPEUTICS, INC. (NASDAQ: KYMR), A CLIN...
Více zde

KYMERA THERAPEUTICS TO PARTICIPATE IN UPCOMING FEBRUARY INVESTOR CONFERENCES

30-01-2025
WATERTOWN, MASS., JAN. 30, 2025 (GLOBE NEWSWIRE) --   KYMERA THERAPEUTICS, INC. (NASDAQ: KYMR), A C...
Více zde

KYMERA THERAPEUTICS OUTLINES KEY 2025 OBJECTIVES AND STRATEGY TO ADVANCE INDUSTRY LEADING PORTFOLIO OF ORAL IMMUNOLOGY PROGRAMS

14-01-2025
KT-621 (STAT6) PHASE 1 HEALTHY VOLUNTEER TRIAL ONGOING, WITH DATA EXPECTED IN 2Q25 KYMERA PLANS TO I...
Více zde

KYMERA THERAPEUTICS TO PRESENT AT THE 43RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE ON JANUARY 14

07-01-2025
WATERTOWN, MASS., JAN. 07, 2025 (GLOBE NEWSWIRE) -- KYMERA THERAPEUTICS, INC. (NASDAQ: KYMR), A CLIN...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2026-01-13 00:00:008-KStáhnout
2025-12-10 00:00:008-KStáhnout
2025-12-08 00:00:008-KStáhnout
2025-11-04 00:00:008-KStáhnout
2025-11-04 00:00:0010-QStáhnout
2025-09-03 01:00:008-KStáhnout
2025-09-03 00:00:008-KStáhnout
2025-08-11 01:00:008-KStáhnout
2025-08-11 01:00:0010-QStáhnout
2025-08-11 00:00:008-KStáhnout
2025-08-11 00:00:0010-QStáhnout
2025-06-27 01:00:008-KStáhnout
2025-06-27 00:00:008-KStáhnout
2025-06-25 01:00:008-KStáhnout
2025-06-25 00:00:008-KStáhnout
2025-06-02 01:00:008-KStáhnout
2025-06-02 00:00:008-KStáhnout
2025-05-09 01:00:008-KStáhnout
2025-05-09 01:00:0010-QStáhnout
2025-05-09 00:00:008-KStáhnout
2025-05-09 00:00:0010-QStáhnout
2025-03-03 00:00:008-KStáhnout
2025-03-02 23:00:008-KStáhnout
2025-02-27 00:00:008-KStáhnout
2025-02-27 00:00:0010-KStáhnout
2025-02-26 23:00:008-KStáhnout
2025-02-26 23:00:0010-KStáhnout
2025-01-14 00:00:008-KStáhnout
2025-01-13 23:00:008-KStáhnout
2024-10-31 00:00:008-KStáhnout
2024-10-31 00:00:0010-QStáhnout
2024-10-30 23:00:008-KStáhnout
2024-10-30 23:00:0010-QStáhnout
2024-08-20 01:00:008-KStáhnout
2024-08-20 00:00:008-KStáhnout
2024-08-07 01:00:008-KStáhnout
2024-08-07 01:00:0010-QStáhnout
2024-08-07 00:00:008-KStáhnout
2024-08-07 00:00:0010-QStáhnout
2024-07-08 01:00:008-KStáhnout
2024-07-08 00:00:008-KStáhnout
2024-06-20 01:00:008-KStáhnout
2024-06-20 00:00:008-KStáhnout
2024-05-02 01:00:008-KStáhnout
2024-05-02 01:00:0010-QStáhnout
2024-05-02 00:00:008-KStáhnout
2024-05-02 00:00:0010-QStáhnout
2024-04-01 01:00:008-KStáhnout
2024-04-01 00:00:008-KStáhnout
2024-02-22 00:00:008-KStáhnout
2024-02-22 00:00:0010-KStáhnout
2024-02-21 23:00:008-KStáhnout
2024-02-21 23:00:0010-KStáhnout
2024-01-05 00:00:008-KStáhnout
2024-01-04 23:00:008-KStáhnout
2024-01-04 00:00:008-KStáhnout
2024-01-03 23:00:008-KStáhnout
2023-11-02 00:00:008-KStáhnout
2023-11-02 00:00:0010-QStáhnout
2023-11-01 23:00:008-KStáhnout
2023-11-01 23:00:0010-QStáhnout
2023-08-03 01:00:008-KStáhnout
2023-08-03 01:00:0010-QStáhnout
2023-08-03 00:00:008-KStáhnout
2023-08-03 00:00:0010-QStáhnout
2023-06-16 01:00:008-KStáhnout
2023-06-16 00:00:008-KStáhnout
2023-05-22 01:00:008-KStáhnout
2023-05-22 00:00:008-KStáhnout
2023-05-04 01:00:008-KStáhnout
2023-05-04 01:00:0010-QStáhnout
2023-05-04 00:00:008-KStáhnout
2023-05-04 00:00:0010-QStáhnout
2023-03-10 00:00:008-KStáhnout
2023-03-09 23:00:008-KStáhnout
2023-02-27 00:00:008-KStáhnout
2023-02-26 23:00:008-KStáhnout
2023-02-23 00:00:008-KStáhnout
2023-02-23 00:00:0010-KStáhnout
2023-02-22 23:00:008-KStáhnout
2023-02-22 23:00:0010-KStáhnout
2023-01-10 00:00:008-KStáhnout
2023-01-09 23:00:008-KStáhnout
2022-12-14 00:00:008-KStáhnout
2022-12-13 23:00:008-KStáhnout
2022-11-03 00:00:008-KStáhnout
2022-11-03 00:00:0010-QStáhnout
2022-11-02 23:00:008-KStáhnout
2022-11-02 23:00:0010-QStáhnout
2022-10-13 01:00:008-KStáhnout
2022-10-13 00:00:008-KStáhnout
2022-08-19 01:00:008-KStáhnout
2022-08-19 00:00:008-KStáhnout
2022-08-09 01:00:008-KStáhnout
2022-08-09 01:00:0010-QStáhnout
2022-08-09 00:00:008-KStáhnout
2022-08-09 00:00:0010-QStáhnout
2022-07-08 01:00:008-KStáhnout
2022-07-08 00:00:008-KStáhnout
2022-06-16 01:00:008-KStáhnout
2022-06-16 00:00:008-KStáhnout
2022-05-03 01:00:008-KStáhnout
2022-05-03 01:00:0010-QStáhnout
2022-05-03 00:00:008-KStáhnout
2022-05-03 00:00:0010-QStáhnout
2022-04-11 01:00:008-KStáhnout
2022-04-11 00:00:008-KStáhnout
2022-02-24 00:00:008-KStáhnout
2022-02-24 00:00:0010-KStáhnout
2022-02-23 23:00:008-KStáhnout
2022-02-23 23:00:0010-KStáhnout
2022-01-18 00:00:008-KStáhnout
2022-01-17 23:00:008-KStáhnout
2021-12-27 00:00:008-KStáhnout
2021-12-26 23:00:008-KStáhnout
2021-12-16 00:00:008-KStáhnout
2021-12-15 23:00:008-KStáhnout
2021-11-10 00:00:008-KStáhnout
2021-11-10 00:00:0010-QStáhnout
2021-11-09 23:00:008-KStáhnout
2021-11-09 23:00:0010-QStáhnout
2021-10-27 01:00:008-KStáhnout
2021-10-27 00:00:008-KStáhnout
2021-09-16 01:00:008-KStáhnout
2021-09-16 00:00:008-KStáhnout
2021-08-06 01:00:008-KStáhnout
2021-08-06 01:00:0010-QStáhnout
2021-08-06 00:00:008-KStáhnout
2021-08-06 00:00:0010-QStáhnout
2021-06-28 01:00:008-KStáhnout
2021-06-28 00:00:008-KStáhnout
2021-06-17 01:00:008-KStáhnout
2021-06-17 00:00:008-KStáhnout
2021-05-06 01:00:008-KStáhnout
2021-05-06 01:00:0010-QStáhnout
2021-05-06 00:00:008-KStáhnout
2021-05-06 00:00:0010-QStáhnout
2021-03-16 00:00:008-KStáhnout
2021-03-15 23:00:008-KStáhnout
2021-03-11 00:00:008-KStáhnout
2021-03-11 00:00:0010-KStáhnout
2021-03-10 23:00:008-KStáhnout
2021-03-10 23:00:0010-KStáhnout
2021-03-02 00:00:008-KStáhnout
2021-03-01 23:00:008-KStáhnout
2021-01-12 00:00:008-KStáhnout
2021-01-11 23:00:008-KStáhnout
2020-11-05 00:00:008-KStáhnout
2020-11-05 00:00:0010-QStáhnout
2020-11-04 23:00:008-KStáhnout
2020-11-04 23:00:0010-QStáhnout
2020-09-09 01:00:008-KStáhnout
2020-09-09 00:00:008-KStáhnout
2020-09-01 01:00:008-KStáhnout
2020-09-01 00:00:008-KStáhnout
2020-08-25 01:00:008-KStáhnout
2020-08-25 00:00:008-KStáhnout
preloader